These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 17669388

  • 1. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
    Gallacher DJ, Van de Water A, van der Linde H, Hermans AN, Lu HR, Towart R, Volders PG.
    Cardiovasc Res; 2007 Nov 01; 76(2):247-56. PubMed ID: 17669388
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W, Antzelevitch C.
    Circulation; 2000 Aug 08; 102(6):706-12. PubMed ID: 10931813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, Mönnig G, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 08; 18(6):647-54. PubMed ID: 17388913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
    Boulaksil M, Jungschleger JG, Antoons G, Houtman MJ, de Boer TP, Wilders R, Beekman JD, Maessen JG, van der Hulst FF, van der Heyden MA, van Veen TA, van Rijen HV, de Bakker JM, Vos MA.
    Circ Arrhythm Electrophysiol; 2011 Aug 08; 4(4):566-76. PubMed ID: 21622813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Slow delayed rectifier K+ current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles.
    So PP, Backx PH, Dorian P.
    Br J Pharmacol; 2008 Dec 08; 155(8):1185-94. PubMed ID: 18836478
    [Abstract] [Full Text] [Related]

  • 16. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
    Milberg P, Reinsch N, Wasmer K, Mönnig G, Stypmann J, Osada N, Breithardt G, Haverkamp W, Eckardt L.
    Cardiovasc Res; 2005 Feb 01; 65(2):397-404. PubMed ID: 15639478
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W, Antzelevitch C.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):778-86. PubMed ID: 10716483
    [Abstract] [Full Text] [Related]

  • 18. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Oct 01; 303(1):218-25. PubMed ID: 12235254
    [Abstract] [Full Text] [Related]

  • 19. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N, Philp K, Pollard C, Wakefield I, Hammond TG, Valentin JP.
    Fundam Clin Pharmacol; 2004 Apr 01; 18(2):139-51. PubMed ID: 15066127
    [Abstract] [Full Text] [Related]

  • 20. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ, Robertson C, Dhalla AK, Belardinelli L.
    J Pharmacol Exp Ther; 2008 Jun 01; 325(3):875-81. PubMed ID: 18322148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.